Aurora kinase A in gastrointestinal cancers: time to target

A Katsha, A Belkhiri, L Goff, W El-Rifai - Molecular cancer, 2015 - Springer
Gastrointestinal (GI) cancers are a major cause of cancer-related deaths. During the last two
decades, several studies have shown amplification and overexpression of Aurora kinase A …

Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions

AA Dar, A Zaika, MB Piazuelo, P Correa… - … Journal of the …, 2008 - Wiley Online Library
BACKGROUND Upper gastrointestinal adenocarcinomas are a common cause of cancer‐
related deaths. In this study, the authors investigated the prevalence and biological …

The Aurora kinase inhibitors in cancer research and therapy

J Cicenas - Journal of cancer research and clinical oncology, 2016 - Springer
Compounds that affect enzymatic function of kinases are valuable for the understanding of
the complex biochemical processes in cells. Aurora kinases (AURKs) play a key role in the …

Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy

R Du, C Huang, K Liu, X Li, Z Dong - Molecular cancer, 2021 - Springer
Aurora kinase A (AURKA) belongs to the family of serine/threonine kinases, whose
activation is necessary for cell division processes via regulation of mitosis. AURKA shows …

Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer

K Sankhe, A Prabhu, T Khan - Chemical biology & drug design, 2021 - Wiley Online Library
Aurora kinases (AURKs) are serine/threonine protein kinases that play a critical role during
cell proliferation. Three isoforms of AURKs reported in mammals include AURKA, AURKB …

Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia

A Katsha, M Soutto, V Sehdev, D Peng… - Gastroenterology, 2013 - Elsevier
Background & Aims Chronic inflammation contributes to the pathogenesis of gastric
tumorigenesis. The aurora kinase A (AURKA) gene is frequently amplified and …

The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells

V Sehdev, DF Peng, M Soutto, MK Washington… - Molecular cancer …, 2012 - AACR
Esophageal adenocarcinomas are poorly responsive to chemotherapeutics. This study
aimed to determine the levels of Aurora kinase A (AURKA) and the therapeutic potential of …

Activation of EIF4E by Aurora kinase A depicts a novel druggable axis in everolimus-resistant cancer cells

A Katsha, L Wang, J Arras, OM Omar, J Ecsedy… - Clinical Cancer …, 2017 - AACR
Abstract Purpose: Aurora kinase A (AURKA) is overexpressed in several cancer types,
making it an attractive druggable target in clinical trials. In this study, we investigated the role …

Aurora kinase B inhibition: a potential therapeutic strategy for cancer

NA Borah, MM Reddy - Molecules, 2021 - mdpi.com
Aurora kinase B (AURKB) is a mitotic serine/threonine protein kinase that belongs to the
aurora kinase family along with aurora kinase A (AURKA) and aurora kinase C (AURKC) …

Aurora kinase A, a synthetic lethal target for precision cancer medicine

PK Mou, EJ Yang, C Shi, G Ren, S Tao… - Experimental & Molecular …, 2021 - nature.com
Recent advances in high-throughput sequencing technologies and data science have
facilitated the development of precision medicine to treat cancer patients. Synthetic lethality …